Organization Name
seqWellAnnounced Date Funding Type Series C Funding Stage Late Stage Venture Money Raised
Overview
Lead Investors
CodexisCodexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.
Investors
Investor Name | Partners |
|---|---|
![]() Research Corporation Technologies | |
![]() Codexis | |
![]() BroadOak Capital Partners |


